Historical salary details - Dr. Steven M. Paul, M.D., Chairman of the Board, Rapport Therapeutics Inc.
Dr. Steven M. Paul, M.D. is the Chairman of the Board of Rapport Therapeutics Inc.. They also hold 2 other positions in Sage Therapeutics Inc and Karuna Therapeutics Inc.
Dr. Steven M. Paul, M.D.
Chairman of the Board
$ 699.1 K
Gross Remuneration
-
Current Company
Rapport Therapeutics Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Rapport Therapeutics Inc. | Chairman of the Board | 671.2 K | - |
| 2024 | Sage Therapeutics Inc | Independent Director | 27.8 K | - |
| 2024 | Karuna Therapeutics Inc | Director | - | - |
| 2023 | Sage Therapeutics Inc | Independent Director | - | - |
| 2023 | Karuna Therapeutics Inc | President, Research and Development, Chief Scienti | - | - |
| 2022 | Sage Therapeutics Inc | Independent Director | 254.9 K | -52.1 % |
| 2022 | Alnylam Pharmaceuticals Inc | President, Research and Development, Chief Scienti | 24.2 K | -94.9 % |
| 2022 | Voyager Therapeutics Inc | President, Research and Development, Chief Scienti | 19.5 K | -77.2 % |
| 2022 | Voyager Therapeutics Inc | Director | - | - |
| 2022 | Karuna Therapeutics Inc | President, Research and Development, Chief Scienti | - | - |
| 2022 | Alnylam Pharmaceuticals Inc | Independent Director | - | - |
| 2021 | Sage Therapeutics Inc | Independent Director | 531.7 K | 83.9 % |
| 2021 | Alnylam Pharmaceuticals Inc | Independent Director | 472.5 K | 0.3 % |
| 2021 | Voyager Therapeutics Inc | Director | 85.8 K | -46.1 % |
| 2021 | Karuna Therapeutics Inc | Chairman of the Board, President and Chief Executi | - | - |
| 2020 | Alnylam Pharmaceuticals Inc | Independent Director | 470.9 K | -1.0 % |
| 2020 | Sage Therapeutics Inc | Independent Director | 289.2 K | -74.4 % |
| 2020 | Voyager Therapeutics Inc | Director | 159.3 K | -44.9 % |
| 2020 | Karuna Therapeutics Inc | Chairman of the Board, President and Chief Executi | - | - |
| 2019 | Sage Therapeutics Inc | Independent Director | 1.1 M | 9.4 % |
| 2019 | Alnylam Pharmaceuticals Inc | Independent Director | 475.7 K | -29.5 % |
| 2019 | Voyager Therapeutics Inc | Director | 289.1 K | 1214.0 % |
| 2019 | Karuna Therapeutics Inc | Chairman of the Board, President and Chief Executi | - | - |
| 2018 | Sage Therapeutics Inc | Independent Director | 1.0 M | 42.6 % |
| 2018 | Alnylam Pharmaceuticals Inc | Independent Director | 674.9 K | 20.0 % |
| 2018 | Voyager Therapeutics Inc | Director | 22 K | - |
| 2018 | Karuna Therapeutics Inc | Chairman of the Board, President and Chief Executi | - | - |
| 2017 | Sage Therapeutics Inc | Independent Director | 725.5 K | 124.5 % |
| 2017 | Alnylam Pharmaceuticals Inc | Independent Director | 562.6 K | 8.5 % |
| 2017 | Voyager Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2016 | Alnylam Pharmaceuticals Inc | Independent Director | 518.7 K | -43.7 % |
| 2016 | Sage Therapeutics Inc | Independent Director | 323.2 K | -58.3 % |
| 2016 | Voyager Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2015 | Alnylam Pharmaceuticals Inc | Independent Director | 922.1 K | 18.8 % |
| 2015 | Sage Therapeutics Inc | Independent Director | 774.5 K | 712.1 % |
| 2015 | Voyager Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2014 | Alnylam Pharmaceuticals Inc | Independent Director | 776.4 K | 169.8 % |
| 2014 | Sage Therapeutics Inc | Independent Director | 95.4 K | -56.6 % |
| 2014 | Voyager Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2013 | Alnylam Pharmaceuticals Inc | Independent Director | 287.8 K | 93.5 % |
| 2013 | Sage Therapeutics Inc | Independent Director | 219.8 K | - |
| 2012 | Alnylam Pharmaceuticals Inc | Independent Director | 148.8 K | 13.8 % |
| 2011 | Alnylam Pharmaceuticals Inc | Independent Director | 130.7 K | -41.6 % |
| 2010 | Alnylam Pharmaceuticals Inc | Independent Director | 223.7 K | - |